Location History:
- Salt Lake City, UT (US) (2003)
- Mountain View, CA (US) (2013 - 2022)
Company Filing History:
Years Active: 2003-2022
Title: Innovations in Treatment: The Patents of Louis Monti
Introduction
Louis Monti, an esteemed inventor based in Mountain View, CA, has made significant contributions to the field of medical treatment through his innovative approaches. With a total of five patents to his name, Monti focuses primarily on advancements in treatment methodologies that can notably improve patient care and outcomes.
Latest Patents
Among his latest inventions are two notable patents that stand out for their therapeutic potential. The first patent, titled "16α,17α-Epoxy-10β-hydroxyestr-4-en-3-one," presents a novel treatment for migraines through nasal administration. The second patent, "Pregn-4-en-20-yn-3β-one," addresses depressive disorders and offers a similar method of delivery via the nasal route. These innovations reflect Monti's dedication to developing effective treatments that leverage non-invasive administration techniques.
Career Highlights
Louis Monti's professional journey has been closely associated with Pherin Pharmaceuticals, Inc., a company that has been instrumental in fostering his research and development undertakings. His work within this organization showcases the intersection of creativity and clinical application, and his contributions are paving the way for future advancements in therapeutic treatments.
Collaborations
Throughout his career, Monti has collaborated with notable colleagues, including David L Berliner and Clive L Jennings-White. These partnerships highlight the collaborative spirit inherent in the field of innovation, allowing for diverse perspectives and expertise to converge in the pursuit of groundbreaking inventions.
Conclusion
Louis Monti's contributions as an inventor, particularly in the area of medical treatments, underscore the vital role of innovation in healthcare. With his focus on effective delivery mechanisms and therapeutic strategies, Monti continues to exemplify the spirit of invention, promising potential improvements for patients dealing with migraines and depressive disorders. His work not only reflects individual achievement but also a collective advancement in the medical field.